Company Overview and News

 
BMC Software Is Working With Goldman, Credit Suisse on Sale - Bloomberg

2018-05-18 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Credit Suisse (CS) Presents At Keefe, Bruyette & Woods: European Financial Conference 2018 - Slideshow

2018-05-16 seekingalpha
The following slide deck was published by Credit Suisse Group AG in conjunction with this event.

 
Bond Yields at 3.5% Would Spur Stock Exodus, Credit Suisse Says - Bloomberg

2018-05-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Bitcoin Mining Equipment Maker Canaan Files for $1 Billion IPO - Bloomberg

2018-05-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Ex-Goldman trader hires old rivals to build a crypto empire

2018-05-13 nzherald.co.nz
Yuzo Kano is trying to build a global cryptocurrency powerhouse, one former financier at a time.

 
Bank Stock Roundup: Optimism on Economic Growth Continues, WFC & JPM in Focus

2018-05-11 zacks
Over the last five trading days, performance of banking stocks was bullish. Strong economic growth, desired inflation and a steady labor market boosted investors’ confidence. Moreover, the recent upswing in oil prices is expected to improve near-term inflation outlook, thereby smoothing the path to rise in interest rates. Mortgage rates also slightly improved to 4.55%, as money was pulled out of the bond market.

 
Bear of the Day: Applied Optoelectronics (AAOI)

2018-05-11 zacks
Optical networking equipment companies like Applied Optoelectronics (AAOI - Free Report) are no stranger to the cellar of the Zacks Rank lately as a slowdown in Chinese datacenter demand and heated competition erode their sales and earnings power. AAOI, in fact, has spent all of 2018 as a Zacks #5 Rank Strong Sell, since it was trading above $38 and fell to $22. And this week's earnings report gave analysts no reason to turn that trend around.

 
Bear Of The Day Briggs And Stratton (BGG)

2018-05-10 zacks
Briggs & Stratton (BGG - Free Report) is a Zacks Rank #5 (Strong Sell) despite having posted a beat at its most recent earnings event. Let's take a look at why this stock can have a solid Value Style Score of A as well as a strong Growth Score of B and still be The Bear Of The Day.

 
Ex-Goldman trader Yuzo Kano is hiring old rivals to build a cryptocurrency empire in Tokyo

2018-05-10 japantimes.co.jp
Yuzo Kano is trying to build a global cryptocurrency powerhouse, one former financier at a time.

 
Capital One to Sell $17B of Mortgages & Resume Share Buyback

2018-05-09 zacks
As part of its efforts to do away with less profitable businesses, Capital One (COF - Free Report) will sell roughly $17 billion of first and second lien mortgages to DLJ Mortgage Capital Inc., a subsidiary of Credit Suisse Group AG (CS - Free Report) . The deal, expected to close later this quarter, is expected to result in one-time gain for Capital One. Notably, in November 2017, Capital One had announced its intention to stop issuing residential-mortgage loans and home-equity lines of credit.

 
Bear of the Day: Skechers U.S.A (SKX)

2018-05-09 zacks
After a promising start to 2018, Footwear and Apparel maker Skechers (SKX - Free Report) has fallen on hard time in the last two weeks, shedding nearly 30% of its market value after issuing disappointing guidance with its Q1 earnings report.

1
Stunned investors in Singapore tech darling suffer 33% loss

2018-05-09 thestar.com.my
All eyes in the country’s financial community have been on Venture Corp, an electronics stock that more than tripled since April 2016 to become -- at one point -- a US$6.5bil firm. So meteoric was its advance that Venture became the only technology company listed on Singapore’s blue-chip 30-member Straits Times Index. - Bloomberg

 
Bear of the Day: Southwest Airlines (LUV)

2018-05-08 zacks
Southwest Airlines Co. (LUV - Free Report) is suffering from being in an out-of-favor industry. The full year estimates have been cut on this Zacks Rank #5 (Strong Sell). Southwest Airlines operates a low cost airline in the United States and 10 other countries. Based in Dallas, it carries over 120 million passengers a year. Met the Estimate in the First Quarter On Apr 26, it reported its first quarter results and met the Zacks Consensus of $0.

 
Bear of the Day: Credit Suisse Group (CS)

2018-05-07 zacks
Amid unpredictable trading and market-wide volatility, investors should do their best to avoid stocks with questionable outlooks and stretched valuations. One such example is Credit Suisse (CS - Free Report) , which currently sports a Zacks Rank #5 (Strong Sell) and a “D” grade for Value in our Style Scores system.

1
European Banking Stocks Look Like a Bargain - Bloomberg

2018-05-04 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Related Articles

SGMO: Sangamo BioSciences and Research Report

2018-05-19 - Asif

OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...

HMNY: Helios and Matheson Analytics and Research Report

2018-05-19 - Asif

Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...

BSTG: Biostage Analysis and Research Report

2018-05-17 - Asif

Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...

CUSIP: 22539T274